Skip to content

TWF1 inhibition overcomes cisplatin resistance in NSCLC by inducing ferroptosis via p53-dependent SLC7A11 repression and autophagy-mediated glutathione metabolism reprogramming

Sep 2026 · Cancer Gene Therapy · Vol 33, pp. 1126 - 1140 · 0 citations · 56 references
Medicine

TL;DR

TTF1 is identified as a critical regulator of cisplatin resistance and ferroptosis, highlighting the therapeutic potential of TWF1 inhibition combined with cisplatin to overcome chemoresistance, possibly providing new strategies for improving NSCLC treatment outcomes.

View source

Similar papers

Aug 2026

Mitocurcumin disrupts glutathione balance by modulating Klf9/GSR axis to overcome platinum resistance in non-small cell lung cancer and restores immune surveillance in cold tumor.

Chemoresistance remains a major barrier in non-small cell lung cancer (NSCLC) therapy. Glutathione reductase (GSR), a central regulator of glutathione redox homeostasis, has been implicated in tumor survival, yet its role in non-small cell lung cancer (NSCLC) chemoresistance remains unclear. We demonstrated that GSR is...

G. Panigrahi, Khushboo A Gandhi, Amisha Joshi et al. · 0 citations
Sep 2026

Glutathione-Driven Redox Inducer with Disruption of the SLC7A11/GSH/GPX4 Axis for Enhanced Ferroptotic Therapy.

A glutathione-responsive metal–organic framework nanoplatform for the co-delivery of curcumin and a GPX4-targeting antisense oligonucleotide (ASO) demonstrated robust anticancer effects in 3D multicellular tumor spheroids with a promoted oxidative imbalance.

Sen Li, Wen-Tao Wang, Yi-Zhang Chen et al. · 1 citation
Open access Jan 2026

GPR39 Suppresses Ferroptosis via the Nrf2/SLC7A11 Axis and Reduces the Sensitivity of Colorectal Cancer to Anti‐PD‐1 Immunotherapy

In vivo, GPR39 knockdown significantly potentiated the antitumor activity of PD‐1 blockade, as evidenced by suppressed tumor progression accompanied by enhanced infiltration of CD8+ T cells, whereas ferroptosis inhibition abrogated these effects.

Cong Zhou, Xiao-Ling Fang, Jia-Ying Lin et al. · 0 citations
Open access Sep 2026

Hypoxia confers ferroptosis resistance in glioma cells via HIF-1α/SREBP1-mediated regulation of lipid metabolism

The role of the HIF-1α-SREBP1-FASN/SCD1 signaling axis in ferroptosis regulation in glioma is systematically elucidated, providing important theoretical foundations and experimental support for developing HIF-1α-targeted ferroptosis therapies.

Zhong-Jun Shen, Yao Zhao, Ming-Bo Jia et al. · 0 citations
Sep 2026

UBR5-KDM5A axis rewires redox metabolism to confer cisplatin resistance in triple-negative breast cancer via the cAMP-PKA-SIRT3 cascade.

These findings establish the UBR5-KDM5A-cAMP-PKA-SIRT3 axis as a central regulator of cisplatin resistance in TNBC and highlight KDM5A as a promising therapeutic target for combination treatment strategies.

Ming-Kai Gong, Fan Liang, Hu Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.